Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2005 1
2009 2
2010 1
2011 1
2012 2
2014 1
2017 2
2018 2
2019 1
2020 3
2021 2
2022 5
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
[Review of nutritional components in Covid-19: what about micronutrients?].
Bost M, Richard E, Redonnet-Vernhet I, Parant F, Boulet L, Dupré T, Collin-Chavagnac D, Mesli S, Beauvieux MC; Groupe de Travail de la SFBC « Marqueurs biochimiques de Covid-19 ». Bost M, et al. Among authors: parant f. Ann Biol Clin (Paris). 2022 Jul 1;80(4):319-331. doi: 10.1684/abc.2022.1741. Ann Biol Clin (Paris). 2022. PMID: 36099350 Review. French.
Clinical improvement after Essure® devices removal: a systematic review.
Miguet-Bensouda C, Parant F, Grenet G, Cerruto E, Nohuz E, Chene G. Miguet-Bensouda C, et al. Among authors: parant f. Eur J Contracept Reprod Health Care. 2023 Aug;28(4):238-248. doi: 10.1080/13625187.2023.2236741. Epub 2023 Jul 19. Eur J Contracept Reprod Health Care. 2023. PMID: 37466355 Review.
Daptomycin pharmacokinetic/pharmacodynamic target in staphylococcal infections.
Garreau R, Pham TT, Bourguignon L, Millet A, Parant F, Bussy D, Desevre M, Franchi V, Ferry T, Goutelle S. Garreau R, et al. Among authors: parant f. Clin Infect Dis. 2024 Jan 17:ciae018. doi: 10.1093/cid/ciae018. Online ahead of print. Clin Infect Dis. 2024. PMID: 38236297 No abstract available.
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G. Benaboud S, et al. Among authors: parant f. J Antimicrob Chemother. 2023 Mar 2;78(3):853-854. doi: 10.1093/jac/dkad009. J Antimicrob Chemother. 2023. PMID: 36683308 No abstract available.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Among authors: parant f. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
35 results